AstraZeneca widens cancer immunotherapy net with Advaxis trial
July 22, 2014 at 02:33 AM EDT
LONDON, July 22 (Reuters) - AstraZeneca is casting its net wider in the hot cancer immunotherapy field through a clinical trial collaboration with U.S. biotech firm Advaxis that will test drugs from both companies in combination.